MEDICAL AUTOMATION EXPERTS


Terry Sharrer's bio:

Dr. Sharrer began as Executive Director, Medical Innovation and Transformation Institute, with the Inova Health System (Fairfax, VA) in July 2007. Formerly, he was the Curator of Health Sciences at the National Museum of American History, Smithsonian Institution, where he had worked for thirty-six years.

Terry Sharrer speaks and writes about a range of life science subjects. In 1987, he co-organized an exhibition titled "The Search for Life: Genetic Technology in the 20th Century." This show also was the inaugural exhibition for the DNA Learning Center at Cold Spring Harbor Laboratory in New York. He has done video documentaries on the Human Genome Project, the beginning of gene therapy, and the molecular biology of cancer. He holds a PhD in history from the University of Maryland, has authored some three dozen publications-including A Kind of Fate, Agricultural Change in Virginia, 1861-1920 (about the biological consequences of the Civil War and the beginning of germ theory practices, Iowa State University Press, 2000)-and currently is writing a history of molecular medicine. For outreach work, has served as Chairman of the Board of Directors of the National Foundation for Cancer Research (Bethesda, MD), board member of the Carilion Biomedical Institute (Roanoke, VA), board member, Immune Deficiency Foundation (Towson, MD), and board member, Inova Fairfax Hospital Cancer Advisory Committee (Fairfax, VA).

Currently, his public service includes: board member of the Fund for Inherited Disease Research (Bryn Mawr, PA); and Science Advisor, for the Loudoun County, VA Department of Economic Development, the Clarke County VA Education Foundation, and the Arizona Science Alliance. With his wife Patty, and sons Alex, age 13, and Nicholas, age 17, he lives in Hamilton, Loudoun County, VA.

Disclosure: G. Terry Sharrer, PhD has stock dividends in Merck and Pfizer.

Terry Sharrer's posts:

Lab on a CD Disk-Like Device

June 20, 2017 | | Posted in Newsletter

MIT Makerspaces Microfluidics Devices
Makerspaces are publically accessed R&D facilities for which users pay a fee, like a health club membership. [MORE]

Hospital Metrics: Targets for Improvement

June 20, 2017 | | Posted in Newsletter

Scott Becker, J.D., C.P.A.
“The list king,” Scott Becker, has another of his insightful listings of hospital metrics—this one, 230 hospital [MORE]

Smart Contact Lens for Diabetes and Glaucoma Monitoring

June 20, 2017 | | Posted in Newsletter

New Contact Lens Senses Glaucoma and Diabetes
This piece reports on smart contact lenses developed by two university labs in South [MORE]

Eppendorf’s Mini Bioreactor

June 20, 2017 | | Posted in Newsletter

Eppendorf AG’s DASbox® Mini Bioreactor System
While this piece is an advertisement for a commercial product, it merits special mention for [MORE]

This Year’s Award Winners in Telemedicine

June 20, 2017 | | Posted in Newsletter

Telemedicine
Over the last 20 years, telemedicine has demonstrated not only hundreds of useful applications, but also hinted at a new [MORE]

Inhaled Insulin for Treating Alzheimer’s

June 20, 2017 | | Posted in Newsletter

Nasal Spray
For several years, diabetes researchers and Alzheimer’s researcher have suspected that AD may actually be a fourth kind of [MORE]

Automating Rare Genetic Disease Diagnosis

June 20, 2017 | | Posted in Newsletter

DNA
Computational biologists at Cambridge University and King Abdullah University of Science and Technology have written an algorithm called “PHenomeNET Variant [MORE]

MIT’s Microfluidics Device to Detect Plasma Cells

June 13, 2017 | | Posted in Newsletter

MIT Multiple Myeloma Microfluidics
Multiple myeloma comes from a proliferation of white blood cells (plasma cells) that result in overproduction of [MORE]

Rapid Protein Screening

June 13, 2017 | | Posted in Newsletter

Rapid Screening Machine
Biochemists at Penn State have developed a method for rapid screening of proteins (even in living cells) that [MORE]

CRISPR Diagnostics for Infectious Diseases

June 13, 2017 | | Posted in Newsletter

MIT Professors Collins and Zhang SHERLOCK Developers
CRISPR-Cas9 gene editing has been thought to be most useful in altering DNA, rather [MORE]

Combination Virus and Human Antibodies to Deal with Antibiotic Resistant Bacteria

June 13, 2017 | | Posted in Newsletter

Lysibodies
Unlike a killer asteroid heading toward Earth, the toll of antibiotic resistant bacteria can be seen coming—or actually having come [MORE]

Nanoparticles Reprogram Immune Cells

June 13, 2017 | | Posted in Newsletter

Nanoparticles Reprogram Immune Cells
Here’s a good question: can nanoparticle technology transform immunotherapy for cancer? From researchers at the Fred Hutchinson [MORE]

Urine Test for Ovarian Tumors

June 13, 2017 | | Posted in Newsletter

MIT Nanoparticles Detect Ovarian Cancer in Urine
By the best methods currently, the smallest detectable ovarian tumor has already reached 1 [MORE]

Hacking the Robots

June 13, 2017 | | Posted in Newsletter

Hardly a day passes without some news about cyber insecurity. Banks, movie studios, many kinds of manufactures, and universities are [MORE]